Pantoprazole Drug Interactions: What to Avoid and What to Tell Your Doctor

Pantoprazole (Protonix) has a generally favorable drug interaction profile compared to other PPIs — but it still has important interactions that every patient and prescriber should know about. Some are serious enough to be contraindicated. Others simply require monitoring or dose adjustments.

Here's a complete, organized overview of pantoprazole drug interactions.

Contraindicated Combinations: Do Not Use Together

These drug combinations with pantoprazole are contraindicated — meaning they should never be used together:

Rilpivirine (Edurant) and rilpivirine-containing regimens (Complera, Odefsey, Juluca): Pantoprazole raises stomach pH, dramatically reducing rilpivirine absorption. This can cause HIV treatment failure and the development of drug resistance. ALL PPIs are contraindicated with rilpivirine. If acid suppression is needed in patients on rilpivirine, an H2 blocker (famotidine) is the only option.

Nelfinavir (Viracept): Pantoprazole reduces nelfinavir plasma levels through both pH-related and CYP2C19-mediated mechanisms, potentially causing virologic failure.

Major Interactions: Use Alternatives If Possible

Methotrexate (Trexall, Otrexup): PPIs including pantoprazole may increase methotrexate levels by reducing renal tubular secretion, increasing the risk of methotrexate toxicity. Temporary discontinuation of pantoprazole around methotrexate dosing is sometimes recommended — discuss with your oncologist or rheumatologist.

Mycophenolate mofetil (CellCept): Pantoprazole significantly reduces the absorption of mycophenolate's active metabolite (MPA) — by up to 78% in some studies. Transplant patients on mycophenolate may need dosage adjustments when starting or stopping pantoprazole.

Atazanavir (Reyataz): The absorption of atazanavir is pH-dependent and drops significantly at higher gastric pH. PPIs should be avoided with atazanavir or used only with strict dose adjustments and specialist guidance.

Acalabrutinib (Calquence), neratinib (Nerlynx), nilotinib (Tasigna): These cancer medications have pH-dependent solubility. Higher gastric pH from pantoprazole reduces their absorption, potentially reducing their effectiveness.

Moderate Interactions: Monitor or Adjust

Clopidogrel (Plavix): Pantoprazole reduces the active metabolite of clopidogrel by approximately 14% — less than omeprazole or esomeprazole. Current cardiovascular guidelines consider pantoprazole the preferred PPI for patients on dual antiplatelet therapy, as this modest reduction is not considered clinically significant at standard doses.

Digoxin (Lanoxin): Higher gastric pH from pantoprazole may increase digoxin absorption and elevate serum digoxin levels. Patients on digoxin should have levels monitored when starting or stopping pantoprazole.

Warfarin (Coumadin): Post-marketing reports have noted increased INR and prothrombin time in patients taking PPIs and warfarin concurrently. INR should be monitored more closely when starting, stopping, or changing pantoprazole in patients on warfarin.

Iron salts (ferrous sulfate, ferrous gluconate): Gastric acid is needed for optimal iron absorption. Pantoprazole can reduce iron salt absorption. Iron supplements should ideally be taken 1–2 hours before pantoprazole for best absorption.

Ketoconazole, itraconazole (oral): Oral azole antifungals require an acidic environment for absorption. Pantoprazole reduces their bioavailability and may reduce antifungal efficacy.

Ampicillin: Elevated gastric pH from PPIs can reduce ampicillin absorption.

Food and Supplement Interactions

Calcium carbonate supplements: Calcium carbonate requires gastric acid for absorption. Long-term pantoprazole use may slightly reduce calcium carbonate absorption, contributing to bone density concerns. Calcium citrate is better absorbed with low gastric acid and is preferred for patients on long-term PPIs.

Vitamin B-12 supplements: Long-term pantoprazole use can impair B-12 absorption from food. Patients on pantoprazole for more than 3 years may need B-12 supplementation.

Diagnostic Test Interactions

Pantoprazole can interfere with the following diagnostic tests:

Chromogranin A (CgA) testing: PPIs increase CgA levels (a marker used to detect neuroendocrine tumors), potentially causing false-positive results. Pantoprazole should be discontinued for at least 14 days before CgA testing.

H. pylori urea breath test: PPIs suppress H. pylori, potentially producing false-negative urea breath test results. Pantoprazole should be stopped 1–2 weeks before H. pylori testing.

What to Tell Your Doctor Before Starting Pantoprazole

Before starting pantoprazole, tell your doctor about all medications you take, including:

HIV antiretroviral medications (especially rilpivirine-containing regimens)

Blood thinners (warfarin, clopidogrel)

Methotrexate or mycophenolate

Digoxin or heart medications

Iron, calcium, or B-12 supplements

Any oral antifungals or targeted cancer therapies

See also our complete guide to pantoprazole side effects. And if you need help finding your prescription, medfinder can locate it at a pharmacy near you.